Literature DB >> 29691168

Predicting Failure in Early Acute Prosthetic Joint Infection Treated With Debridement, Antibiotics, and Implant Retention: External Validation of the KLIC Score.

Claudia A M Löwik1, Paul C Jutte1, Eduard Tornero2, Joris J W Ploegmakers1, Bas A S Knobben3, Astrid J de Vries3, Wierd P Zijlstra4, Baukje Dijkstra4, Alex Soriano5, Marjan Wouthuyzen-Bakker6.   

Abstract

BACKGROUND: Debridement, antibiotics, and implant retention (DAIR) is a widely used treatment modality for early acute prosthetic joint infection (PJI). A preoperative risk score was previously designed for predicting DAIR failure, consisting of chronic renal failure (K), liver cirrhosis (L), index surgery (I), cemented prosthesis (C), and C-reactive protein >115 mg/L (KLIC). The aim of this study was to validate the KLIC score in an external cohort.
METHODS: We retrospectively evaluated patients with early acute PJI treated with DAIR between 2006 and 2016 in 3 Dutch hospitals. Early acute PJI was defined as <21 days of symptoms and DAIR performed within 90 days after index surgery. Failure was defined as the need for (1) second DAIR, (2) implant removal, (3) suppressive antimicrobial treatment, or (4) infection-related death within 60 days after debridement.
RESULTS: A total of 386 patients were included. Failure occurred in 148 patients (38.3%). Patients with KLIC scores of ≤2, 2.5-3.5, 4-5, 5.5-6.5, and ≥7 had failure rates of 27.9%, 37.1%, 49.3%, 54.5%, and 85.7%, respectively (P < .001). The receiver-operating characteristic curve showed an area under the curve of 0.64 (95% confidence interval 0.59-0.69). A KLIC score higher than 6 points showed a specificity of 97.9%.
CONCLUSION: The KLIC score is a relatively good preoperative risk score for DAIR failure in patients with early acute PJI and appears to be most useful in clinical practice for patients with low or high KLIC scores.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DAIR; external validation; joint arthroplasty; prosthetic joint infection; risk score

Mesh:

Substances:

Year:  2018        PMID: 29691168     DOI: 10.1016/j.arth.2018.03.041

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  Outcomes of Debridement, Antibiotics and Implant Retention (DAIR) for Periprosthetic Joint Infection in a High-Volume Arthroplasty Centre.

Authors:  Sriganesh Walkay; David Tran Wallace; Vijay Shankar Coimbatore Balasubramaniam; Rohit Maheshwari; Manish Changulani; Martin Sarungi
Journal:  Indian J Orthop       Date:  2022-05-28       Impact factor: 1.033

Review 2.  Treatment patterns and failure rates associated with prosthetic joint infection in unicompartmental knee arthroplasty: A systematic review.

Authors:  Joseph P Barbera; Ryan C Xiao; Christine S Williams; Jashvant Poeran; Calin S Moucha; Darwin D Chen; Brett L Hayden
Journal:  J Orthop       Date:  2022-09-14

3.  Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection.

Authors:  Alberto V Carli; Andy O Miller; Milan Kapadia; Yu-Fen Chiu; Geoffrey H Westrich; Barry D Brause; Michael W Henry
Journal:  J Bone Jt Infect       Date:  2020-03-30

4.  Presence of the neonatal Staphylococcus capitis outbreak clone (NRCS-A) in prosthetic joint infections.

Authors:  Staffan Tevell; Sharmin Baig; Bengt Hellmark; Patricia Martins Simoes; Thierry Wirth; Marine Butin; Åsa Nilsdotter-Augustinsson; Bo Söderquist; Marc Stegger
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

5.  Comparison of the success rate after debridement, antibiotics and implant retention (DAIR) for periprosthetic joint infection among patients with or without a sinus tract.

Authors:  Wang Deng; Rui Li; Hongyi Shao; Baozhan Yu; Jiying Chen; Yixin Zhou
Journal:  BMC Musculoskelet Disord       Date:  2021-10-21       Impact factor: 2.362

6.  If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study.

Authors:  Mark Beldman; Claudia Löwik; Alex Soriano; Laila Albiach; Wierd P Zijlstra; Bas A S Knobben; Paul Jutte; Ricardo Sousa; André Carvalho; Karan Goswami; Javad Parvizi; Katherine A Belden; Marjan Wouthuyzen-Bakker
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

7.  A protocol for periprosthetic joint infections from the Northern Infection Network for Joint Arthroplasty (NINJA) in the Netherlands.

Authors:  W P Zijlstra; J J W Ploegmakers; G A Kampinga; M L Toren-Wielema; H B Ettema; B A S Knobben; P C Jutte; M Wouthuyzen-Bakker
Journal:  Arthroplasty       Date:  2022-04-11

8.  Symptom duration is associated with failure of periprosthetic joint infection treated with debridement, antibiotics and implant retention.

Authors:  Hongyi Shao; Rui Li; Wang Deng; Baozhan Yu; Dejin Yang; Yixin Zhou; Jiying Chen
Journal:  Front Surg       Date:  2022-08-31

Review 9.  Methodological Challenges in Predicting Periprosthetic Joint Infection Treatment Outcomes: A Narrative Review.

Authors:  Elise Naufal; Marjan Wouthuyzen-Bakker; Sina Babazadeh; Jarrad Stevens; Peter F M Choong; Michelle M Dowsey
Journal:  Front Rehabil Sci       Date:  2022-07-11

Review 10.  Treatment of Prosthetic Joint Infection with Debridement, Antibiotics and Irrigation with Implant Retention - a Narrative Review.

Authors:  Ricardo Sousa; Miguel Araújo Abreu
Journal:  J Bone Jt Infect       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.